Testicular cancer mortality statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Deaths

Deaths from testicular cancer, 2015-2017, UK.

Proportion of all deaths

Percentage testicular cancer contributes to total cancer deaths, 2015-2017, UK

 

Age

Peak mortality rate for testicular cancer, 2015-2017, UK

Trend over time

Change in testicular cancer mortality rates since the early 1970s, Males, UK

Testicular cancer is not among the 20 most common causes of cancer death in males in the UK, accounting for less than 1% of all cancer deaths in males (2017). In females and males combined, testicular cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of cancer deaths (2017).[1-3]

Testicular cancer mortality rates (European age-standardised (AS) rates) Open a glossary item are similar to the UK average in all the UK constituent countries.

Testicular Cancer (C62), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK, 2017

  England Scotland Wales Northern Ireland UK
Male Deaths 57 4 2 2 65
Crude Rate 0.2 0.2 0.1 0.2 0.2
AS Rate 0.2 0.2 0.1 0.2 0.2
AS Rate - 95% LCL 0.2 0.0 0.0 0.0 0.2
AS Rate - 95% UCL 0.3 0.3 0.3 0.5 0.3
Persons Deaths 57 4 2 2 65
Crude Rate 0.1 0.1 0.1 0.1 0.1
AS Rate 0.1 0.1 0.1 0.1 0.1
AS Rate - 95% LCL 0.1 0.0 0.0 0.0 0.1
AS Rate - 95% UCL 0.1 0.1 0.2 0.2 0.1

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C62.

Last reviewed:

Testicular cancer mortality is weakly related to age, with the highest mortality rates being in the 90+ age group. In the UK in 2015-2017, on average each year almost a tenth (8%) of deaths were in males aged 75 and over.[1-3] This is a much lower proportion of deaths in older age groups compared with most cancers.

Age-specific mortality rates rise steeply from around age 10-14 then remain stable (apparent fluctuations are not statistically significant). The highest rates are in the 90+ age group.  

Testicular Cancer (C62), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Male Population, UK, 2015-2017

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, ICD-10 C62..

Last reviewed:

Testicular cancer European age-standardised (AS) mortality rates for males decreased by 83% in the UK between 1971-1973 and 2015-2017.[1-3].

Over the last decade in the UK (between 2005-2007 and 2015-2017), testicular cancer AS mortality rates for males remained stable.[1-3]

Testicular Cancer (C62), European Age-Standardised Mortality Rates per 100,000 Population, Males, UK, 1971-2017

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Testicular cancer mortality rates have decreased overall in all broad age groups in males in the UK since the early 1970s.[1-3] Rates in 0-24s have decreased by 95%, in 25-49s have decreased by 85%, in 50-59s have decreased by 60%, in 60-69s have decreased by 71%, in 70-79s have decreased by 77%, and in 80+s have decreased by 88%.

Testicular Cancer (C62), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Males, UK, 1971-2017

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2017, C62.

Last reviewed:

Testicular cancer mortality rates are projected to fall by 35% in the UK between 2014 and 2035, to fewer than 1 death per 100,000 males by 2035.[1]

Testicular cancer (C62), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

It is projected that 51 deaths from testicular cancer will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C62

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for an association between testicular cancer mortality and deprivation in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 82% higher for males living in the most deprived areas compared with the least deprived.[1]

Testicular Cancer (C62), European Age-Standardised Mortality Rates by Deprivation Quintile, Males, England, 2007-2011

The estimated deprivation gradient in testicular cancer mortality between males living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It has been estimated that there would have been around 13 fewer cancer deaths each year in England during 2007-2011 if all males experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C62

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.